Form 8-K - Current report:
SEC Accession No. 0001104659-24-101333
Filing Date
2024-09-19
Accepted
2024-09-19 16:05:18
Documents
13
Period of Report
2024-09-16
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2424409d1_8k.htm   iXBRL 8-K 24134
  Complete submission text file 0001104659-24-101333.txt   199243

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20240916.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20240916_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20240916_pre.xml EX-101.PRE 22367
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2424409d1_8k_htm.xml XML 3812
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 241310464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)